96 related articles for article (PubMed ID: 2826751)
1. Influence of beta-lactam antibiotics on platelets. II. In vitro effects of some beta-lactam antibiotics on the biochemical responses of rat platelets.
Nakano T; Terawaki A; Arita H
J Pharmacobiodyn; 1987 Aug; 10(8):408-20. PubMed ID: 2826751
[TBL] [Abstract][Full Text] [Related]
2. Normal thrombin binding leads to greater fibrinogen binding and increased platelet aggregation in spontaneously hypertensive rats.
Huzoor-Akbar ; Kundu N; Kornhauser R
Life Sci; 1993; 53(26):1967-74. PubMed ID: 8255159
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
[TBL] [Abstract][Full Text] [Related]
5. Platelets from bleeding Simmental cattle mobilize calcium, phosphorylate myosin light chain and bind normal numbers of fibrinogen molecules but have abnormal cytoskeletal assembly and aggregation in response to ADP.
Searcy GP; Frojmovic MM; McNicol A; Robertson C; Wong T; Gerrard JM
Thromb Haemost; 1994 Feb; 71(2):240-6. PubMed ID: 8191406
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral contraceptives, or lanosterol, on ADP-induced aggregation and binding of 125I-fibrinogen to rat platelets.
McGregor L; Toor B; McGregor JL; Renaud S; Clemetson KJ
Thromb Res; 1984 Mar; 33(5):517-22. PubMed ID: 6719398
[TBL] [Abstract][Full Text] [Related]
7. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
Peerschke EI
Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
9. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
12. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
Oda A; Druker BJ; Smith M; Salzman EW
Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
[TBL] [Abstract][Full Text] [Related]
14. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
15. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
Oliver JA; Albrecht RM
Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
[TBL] [Abstract][Full Text] [Related]
16. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats.
Harfenist EJ; Packham MA; Mustard JF
Blood; 1988 Jan; 71(1):132-6. PubMed ID: 3334894
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine potentiates human platelet activation but is not an aggregating agent.
Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
[TBL] [Abstract][Full Text] [Related]
18. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction.
Krishnamurthi S; Patel Y; Kakkar VV
Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
